#17 – Psychedelic Capitalists Part 2: Pandemic Profiteers and Non-Cooperative Actors
Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implic
Apple Podcasts | Spotify | Deezer | YouTube | RSS
Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.
Watch
Episode links
Calm Down. What’s the Worst Thing That the Wellness Industry Could Do To Psychedelics?
Talking Psychedelic Capitalism In a WeWork Ballroom
Christian Angermayer’s ATAI Life Sciences is Positioned to Take the Psychedelic Throne From MAPS
Making Psychedelics Boring Again: Unless You’re a Privileged Psychedelic Executive, Of Course
Psychedelic Trade Secrets and Get-Rich-Quick Schemes — A Benefit to Investors, a Harm to Progress
Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency
